Citations (31)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Eirini Kanata, Minas Arsenakis & Theodoros Sklaviadis. (2016) Caprine PrP variants harboring Asp-146, His-154 and Gln-211 alleles display reduced convertibility upon interaction with pathogenic murine prion protein in scrapie infected cells. Prion 10:5, pages 391-408.
Read now
Read now
Articles from other publishers (30)
Daniel Shoup & Suzette A. Priola. (2022) Cell biology of prion strains in vivo and in vitro. Cell and Tissue Research 392:1, pages 269-283.
Crossref
Crossref
Aishwarya Agarwal & Samrat Mukhopadhyay. (2022) Prion Protein Biology Through the Lens of Liquid-Liquid Phase Separation. Journal of Molecular Biology 434:1, pages 167368.
Crossref
Crossref
Divya Teja Dondapati, Pradeep Reddy Cingaram, Ferhan Ayaydin, Antal Nyeste, Andor Kanyó, Ervin Welker & Elfrieda Fodor. (2021) Membrane Domain Localization and Interaction of the Prion-Family Proteins, Prion and Shadoo with Calnexin. Membranes 11:12, pages 978.
Crossref
Crossref
Nikol Jankovska, Robert Rusina, Magdalena Bruzova, Eva Parobkova, Tomas Olejar & Radoslav Matej. (2021) Human Prion Disorders: Review of the Current Literature and a Twenty-Year Experience of the National Surveillance Center in the Czech Republic. Diagnostics 11:10, pages 1821.
Crossref
Crossref
Juliana N. Angelli, Yulli M. Passos, Julyana M. A. Brito, Jerson L. Silva, Yraima Cordeiro & Tuane C. R. G. Vieira. (2021) Rabbit PrP Is Partially Resistant to in vitro Aggregation Induced by Different Biological Cofactors. Frontiers in Neuroscience 15.
Crossref
Crossref
Alexandra Louka, Elsa Zacco, Piero Andrea Temussi, Gian Gaetano Tartaglia & Annalisa Pastore. (2020) RNA as the stone guest of protein aggregation. Nucleic Acids Research 48:21, pages 11880-11889.
Crossref
Crossref
Carlo Mustazza, Marco Sbriccoli, Paola Minosi & Carla Raggi. (2020) Small Molecules with Anti-Prion Activity. Current Medicinal Chemistry 27:33, pages 5446-5479.
Crossref
Crossref
Alba Marín-Moreno, Juan Carlos Espinosa & Juan María Torres. 2020. Prions and Neurodegenerative Diseases. Prions and Neurodegenerative Diseases
147
177
.
Antonio Magrì, Giovanni Tabbì, Lorena Maria Cucci, Cristina Satriano, Adriana Pietropaolo, Gaetano Malgieri, Carla Isernia & Diego La Mendola. (2019)
The curious case of opossum prion: a physicochemical study on copper(
ii
) binding to the bis-decarepeat fragment from the protein N-terminal domain
. Dalton Transactions 48:47, pages 17533-17543.
Crossref
Crossref
Nicholas J. Haley, Kahla Merrett, Amy Buros Stein, Dennis Simpson, Andrew Carlson, Gordon Mitchell, Antanas Staskevicius, Tracy Nichols, Aaron D. Lehmkuhl & Bruce V. Thomsen. (2019) Estimating relative CWD susceptibility and disease progression in farmed white-tailed deer with rare PRNP alleles. PLOS ONE 14:12, pages e0224342.
Crossref
Crossref
Teferedegn EY, Tesfaye D & Un C. (2019) Valuing the investigation of Prion diseases in Ethiopia. International Journal of Agricultural Science and Food Technology, pages 001-005.
Crossref
Crossref
Panchanan Maiti & Jayeeta Manna. 2019. Heat Shock Proteins in Neuroscience. Heat Shock Proteins in Neuroscience
85
114
.
Francesca Collu, Enrico Spiga, Nesrine Chakroun, Human Rezaei & Franca Fraternali. (2018) Probing the early stages of prion protein (PrP) aggregation with atomistic molecular dynamics simulations. Chemical Communications 54:57, pages 8007-8010.
Crossref
Crossref
Nataraj S. Pagadala, Trent C. Bjorndahl, Michael Joyce, David S. Wishart, Khajamohiddin Syed & Abdolamir Landi. (2017) The compound (3-{5-[(2,5-dimethoxyphenyl)amino]-1,3,4-thiadiazolidin-2-yl}-5,8-methoxy-2H-chromen-2-one) inhibits the prion protein conversion from PrPC to PrPSc with lower IC50 in ScN2a cells. Bioorganic & Medicinal Chemistry 25:20, pages 5875-5888.
Crossref
Crossref
Andrew R. Castle & Andrew C. Gill. (2017) Physiological Functions of the Cellular Prion Protein. Frontiers in Molecular Biosciences 4.
Crossref
Crossref
Ankit Srivastava, Sakshi Sharma, Sandhya Sadanandan, Sakshi Gupta, Jasdeep Singh, Sarika Gupta, V. Haridas & Bishwajit Kundu. (2017) Modulation of prion polymerization and toxicity by rationally designed peptidomimetics. Biochemical Journal 474:1, pages 123-147.
Crossref
Crossref
Pu Chun Ke, Marc-Antonie Sani, Feng Ding, Aleksandr Kakinen, Ibrahim Javed, Frances Separovic, Thomas P. Davis & Raffaele Mezzenga. (2017) Implications of peptide assemblies in amyloid diseases. Chemical Society Reviews 46:21, pages 6492-6531.
Crossref
Crossref
Victoria Lewis. 2017. Prions. Prions
119
132
.
Tuğçe Birkan, Mesut Şahin, Zübeyde Öztel & Erdal Balcan. (2016) Do prion protein gene polymorphisms induce apoptosis in non-mammals?. Journal of Biosciences 41:1, pages 97-107.
Crossref
Crossref
Victoria Lewis, Vanessa A. Johanssen, Peter J. Crouch, Genevieve M. Klug, Nigel M. Hooper & Steven J. Collins. (2015) Prion protein “gamma-cleavage”: characterizing a novel endoproteolytic processing event. Cellular and Molecular Life Sciences 73:3, pages 667-683.
Crossref
Crossref
Nicholas J. HaleyEdward A. Hoover. (2015) Chronic Wasting Disease of Cervids: Current Knowledge and Future Perspectives. Annual Review of Animal Biosciences 3:1, pages 305-325.
Crossref
Crossref
Timothy D. Kurt, Lin Jiang, Cyrus Bett, David Eisenberg & Christina J. Sigurdson. (2014) A Proposed Mechanism for the Promotion of Prion Conversion Involving a Strictly Conserved Tyrosine Residue in the β2-α2 Loop of PrPC. Journal of Biological Chemistry 289:15, pages 10660-10667.
Crossref
Crossref
Vladimir Espinosa Angarica, Salvador Ventura & Javier Sancho. (2013) Discovering putative prion sequences in complete proteomes using probabilistic representations of Q/N-rich domains. BMC Genomics 14:1.
Crossref
Crossref
Arpana Dutta, Shugui Chen & Witold K. Surewicz. (2013) The effect of β2‐α2 loop mutation on amyloidogenic properties of the prion protein. FEBS Letters 587:18, pages 2918-2923.
Crossref
Crossref
Magdalena Rowinska‐Zyrek, Daniela Valensin, Marek Luczkowski & Henryk Kozlowski. 2013. Mechanisms and Metal Involvement in Neurodegenerative Diseases. Mechanisms and Metal Involvement in Neurodegenerative Diseases
118
162
.
Yvonne Roettger, Inga Zerr, Richard Dodel & Jan-Philipp Bach. (2013) Prion Peptide Uptake in Microglial Cells – The Effect of Naturally Occurring Autoantibodies against Prion Protein. PLoS ONE 8:6, pages e67743.
Crossref
Crossref
Bilkiss B. Issack, Mark Berjanskii, David S. Wishart & Maria Stepanova. (2012) Exploring the essential collective dynamics of interacting proteins: Application to prion protein dimers. Proteins: Structure, Function, and Bioinformatics, pages n/a-n/a.
Crossref
Crossref
Jerson L. Silva, Tuane C.R.G. Vieira, Mariana P.B. Gomes, Luciana P. Rangel, Sandra M.N. Scapin & Yraima Cordeiro. (2011) Experimental approaches to the interaction of the prion protein with nucleic acids and glycosaminoglycans: Modulators of the pathogenic conversion. Methods 53:3, pages 306-317.
Crossref
Crossref
Fernando Bergasa-Caceres & Herschel A. Rabitz. (2010) Low Entropic Barrier to the Hydrophobic Collapse of the Prion Protein: Effects of Intermediate States and Conformational Flexibility. The Journal of Physical Chemistry A 114:26, pages 6978-6982.
Crossref
Crossref
Miquel Adrover, Kris Pauwels, Stephanie Prigent, Cesira de Chiara, Zhou Xu, Céline Chapuis, Annalisa Pastore & Human Rezaei. (2010) Prion Fibrillization Is Mediated by a Native Structural Element That Comprises Helices H2 and H3. Journal of Biological Chemistry 285:27, pages 21004-21012.
Crossref
Crossref